Stock MPARK MLP SAGLIK HIZMETLERI
Add to a list
To use this feature you must be a member
Log inSign up

Financials MLP Saglik Hizmetleri

Equities

MPARK

TREMLPC00021

Healthcare Facilities & Services

Delayed Borsa Istanbul
Other stock markets
 03:21:09 2024-07-17 am EDT 		5-day change 1st Jan Change
379.5 TRY +0.40% Intraday chart for MLP Saglik Hizmetleri +12.69% +154.87%
May. 28 MLP Saglik Hizmetleri A.S. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 19 MLP Saglik Hizmetleri A.S. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,329 4,134 6,212 18,765 30,998 78,638 - -
Enterprise Value (EV) 1 5,372 6,250 8,281 20,817 34,241 81,835 75,984 66,910
P/E ratio 94.1 x 64.1 x 21.3 x 11.6 x 6.84 x 9.7 x 7.79 x 5.99 x
Yield - - - - - 1.27% 1.67% 2.14%
Capitalization / Revenue 0.9 x 1.03 x 1.07 x 1.91 x 1.38 x 2.1 x 1.67 x 1.22 x
EV / Revenue 1.45 x 1.56 x 1.43 x 2.12 x 1.53 x 2.18 x 1.61 x 1.04 x
EV / EBITDA 6.81 x 6.22 x 5.96 x 8.88 x 5.92 x 9.41 x 6.28 x 3.89 x
EV / FCF 10.7 x 8.32 x 7.14 x 15.9 x 10.7 x 24.6 x 18.4 x 9.68 x
FCF Yield 9.36% 12% 14% 6.29% 9.36% 4.07% 5.43% 10.3%
Price to Book 14.5 x 14.6 x 11.5 x 10.4 x 2.45 x 2.57 x 1.32 x 0.76 x
Nbr of stocks (in thousands) 208,037 208,037 208,037 208,037 208,037 208,037 - -
Reference price 2 16.00 19.87 29.86 90.20 149.0 378.0 378.0 378.0
Announcement Date 3/5/20 3/8/21 3/8/22 3/8/23 3/19/24 - - -
1TRY in Million2TRY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,704 4,015 5,796 9,837 22,449 37,464 47,153 64,397
EBITDA 1 788.8 1,005 1,389 2,346 5,784 8,693 12,095 17,189
EBIT 1 522.9 753.6 1,053 1,900 4,241 8,974 10,477 13,253
Operating Margin 14.12% 18.77% 18.17% 19.32% 18.89% 23.95% 22.22% 20.58%
Earnings before Tax (EBT) 1 82.12 185.5 371.9 1,304 5,825 6,422 8,352 10,885
Net income 1 36.25 64.93 290.4 1,619 4,530 4,838 6,569 8,403
Net margin 0.98% 1.62% 5.01% 16.46% 20.18% 12.91% 13.93% 13.05%
EPS 2 0.1700 0.3100 1.400 7.780 21.77 38.98 48.51 63.06
Free Cash Flow 1 502.8 751.3 1,160 1,309 3,203 3,333 4,124 6,909
FCF margin 13.58% 18.71% 20.01% 13.3% 14.27% 8.9% 8.75% 10.73%
FCF Conversion (EBITDA) 63.75% 74.72% 83.49% 55.8% 55.39% 38.34% 34.1% 40.19%
FCF Conversion (Net income) 1,387.09% 1,157.04% 399.26% 80.82% 70.72% 68.9% 62.78% 82.22%
Dividend per Share 2 - - - - - 4.800 6.300 8.100
Announcement Date 3/5/20 3/8/21 3/8/22 3/8/23 3/19/24 - - -
1TRY in Million2TRY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 1 2,542 1,756 2,187 2,230 2,476 2,944 3,474 3,693 4,869 10,414 7,960
EBITDA 1 631.2 366.6 501.9 540.6 589.7 713.3 814.1 895.8 1,700 2,374 1,900
EBIT 477 268.8 - - - - - - - - -
Operating Margin 18.76% 15.31% - - - - - - - - -
Earnings before Tax (EBT) 188.2 - - - - - - - - - -
Net income 1 147.3 125.4 170 406.8 461.7 580.8 244.8 687.1 689.1 2,909 683
Net margin 5.79% 7.14% 7.78% 18.24% 18.65% 19.73% 7.05% 18.61% 14.15% 27.93% 8.58%
EPS - 0.6100 - - - - - - - - -
Dividend per Share - - - - - - - - - - -
Announcement Date 8/12/21 3/8/22 5/10/22 8/11/22 11/7/22 3/8/23 5/9/23 8/8/23 11/7/23 3/19/24 5/28/24
1TRY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,043 2,117 2,069 2,053 3,243 3,197 - -
Net Cash position 1 - - - - - - 2,654 11,728
Leverage (Debt/EBITDA) 2.59 x 2.105 x 1.49 x 0.8751 x 0.5608 x 0.3678 x - -
Free Cash Flow 1 503 751 1,160 1,309 3,203 3,333 4,124 6,909
ROE (net income / shareholders' equity) 10.3% 25.3% 70.7% 138% 40.1% 32.2% 28.1% 23.4%
ROA (Net income/ Total Assets) 1.01% 1.53% 5.63% 22.8% 17.8% - - -
Assets 1 3,577 4,243 5,160 7,092 25,516 - - -
Book Value Per Share 2 1.110 1.360 2.590 8.680 60.90 147.0 287.0 497.0
Cash Flow per Share 2 3.190 4.320 7.940 9.490 21.50 47.60 86.70 109.0
Capex 1 160 148 458 680 1,272 3,733 4,258 4,757
Capex / Sales 4.33% 3.69% 7.91% 6.92% 5.67% 9.96% 9.03% 7.39%
Announcement Date 3/5/20 3/8/21 3/8/22 3/8/23 3/19/24 - - -
1TRY in Million2TRY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for MLP Saglik Hizmetleri

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
378 TRY
Average target price
324.4 TRY
Spread / Average Target
-14.17%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
MLP SAGLIK HIZMETLERI Stock MLP Saglik Hizmetleri
+154.87% 2.38B
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-33.38% 13.49B
IHH HEALTHCARE Stock IHH Healthcare
+5.31% 11.96B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
-4.50% 11.68B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+13.14% 11.1B
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+30.61% 8.77B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+24.64% 7.9B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+8.23% 6.44B
FORTIS HEALTHCARE LIMITED Stock Fortis Healthcare Limited
+16.63% 4.42B
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-6.98% 4.14B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. MPARK Stock
  4. Financials MLP Saglik Hizmetleri